SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " clinical " 100 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
How Fabian Hurzeler Has Changed Maxim De Cuyper At Brighton
The Belgian defender has evolved into a clinical goalscorer, swapping traditional fullback duties for a lethal role ghosting into the box within Hürzeler’s fluid, attacking system.
Making virtual exams routine: what health systems need to do
Clinical validation, patient training, reliable data workflows and clear responsibility for follow-up will determine whether remote examinations can scale.
Your age may not tell the whole story about your health, but your blood could
Researchers analyzed plasma metabolites from 18,476 individuals aged 1 to 96 years and developed two metabolomic aging measures to assess biological aging, chronic disease, and mortality risk. Accelerated metabolomic aging was associated with greater risks of chronic disease and death, while a separate mortality-linked measure provided additional information about health status and disease burden beyond conventional clinical assessments.
FHS seeks businesses for health science clinical rotations
Fredericksburg High School is seeking local businesses and health care organizations willing to provide clinical rotation opportunities for students in the school’s Health Science Clinicals and Practicum program.
Brighton Held 0-0 by Jablonec: Wasteful Seagulls Frustrated
Despite dominating possession in the Czech Republic, Fabian Hürzeler’s side lacked a clinical edge, relying on Bart Verbruggen’s heroics to escape a stubborn Jablonec defense with a draw.
IU Kelley School of Business Expert Weights in on Prediction Markets and Midterm Elections
As prediction markets play a growing role in election forecasting and increasingly compete with traditional polling, Russell Rhoads, clinical associate professor of finance at the Indiana University Kelley School of Business Indianapolis, is available to provide expert analysis and commentary. Rhoads can help audiences understand how prediction markets work, what market odds actually signal about election outcomes, and why investors, analysts, and political observers are payin
U.S. Department of Health and Human Services (HHS) Recommends Science-Based Thresholds to Target Dangerous Enhanced Kratom Products
Kratom products credit: CDPH DEA takes action based on updated recommendation from HHS October 11, 2026 - WASHINGTON - On Friday, the U.S. Department of Health and Human Services relesed the following: The U.S. Department of Health and Human Services (HHS) provided a new recommendation to the Drug Enforcement Administration (DEA) that establishes science-based thresholds for 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl (MGPI), potent opioid compounds associated with products marketed as kratom. The Department of Justice today announced that DEA issued new Notices of Intent reflecting HHS’ updated scientific analysis and recommendations, including a new Notice of Intent for 7-OH and MGPI incorporating HHS’ recommended concentration and ratio thresholds. Following a review of available scientific data and comments, HHS Assistant Secretary for Health Admiral Brian Christine, M.D., recommended that DEA use concentration or ratio-based thresholds to determine which products containing 7-OH and MGPI are subject to Schedule I control for purposes of temporary scheduling of these substances under the Controlled Substances Act. The recommendation is designed to target concentrated or chemically altered products while distinguishing them from natural botanical kratom products, which may contain trace amounts of 7-OH and MGPI. “We are drawing a clear line between natural kratom and dangerous, enhanced opioid products,” said HHS Secretary Robert F. Kennedy, Jr. “We listened to the public, followed the science, and developed a clear recommended threshold for temporary scheduling that targets concentrated 7-OH and MGPI without sweeping natural botanical kratom into Schedule I. The Trump Administration will continue taking decisive action against dangerous products that fuel addiction while making sure our policies are grounded in rigorous science.” Under the recommendation, 7-OH and MGPI would be controlled in Schedule I for purposes of temporary scheduling when either substance alone, or their combined amount when both are present: Exceeds 1 milligram per gram in solid powders, encapsulated material, or other solid forms, or exceeds 1 milligram per milliliter in liquid preparations; or When the mass of mitragynine present divided by the mass of 7-OH, or MGPI, or the combined amount of 7-OH and MGPI if both present, is less than 100. The ratio-based approach reflects the alkaloid composition of natural kratom products and provides a way to identify products intentionally enhanced or concentrated with 7-OH or MGPI. Available scientific data indicate that 7-OH occurs naturally in botanical kratom at relatively low or trace levels, while some evidence reviewed by FDA suggests MGPI may also occur at trace levels in some natural or kratom-derived products. FDA's scientific review found that 7-OH is substantially more potent than morphine in preclinical studies, with available data indicating approximately two to nine times greater potency depending on the study. FDA also identified evidence supporting a meaningful risk of opioid-like physical dependence and withdrawal from MGPI. “Our recommendation gives DEA a scientifically supportable framework to distinguish natural botanical kratom from products that have been concentrated or manipulated to deliver dangerous levels of potent opioid compounds,” said Assistant Secretary for Health Admiral Brian Christine, M.D. “This approach allows us to focus on the products that pose the greatest threat to public health.” In July 2025, following an FDA scientific and medical evaluation, HHS recommended that 7-OH above a specified threshold be placed in Schedule I of the Controlled Substances Act. In July 2026, DEA announced its intent to temporarily schedule 7-OH above a specified threshold, and HHS simultaneously sought public comment on the proposed threshold. DEA subsequently temporarily placed MGPI and two synthetic 7-OH derivatives, MGM-15 and MGM-16, in Schedule I. Since then, questions have emerged about how scheduling could affect natural botanical kratom products potentially containing trace amounts of MGPI. The new HHS recommendation responds to those concerns by providing DEA with a more precise threshold based on both the concentration of 7-OH and MGPI and their relationship to mitragynine, the predominant alkaloid in kratom. HHS and FDA will continue working with DEA to protect Americans from dangerous concentrated and synthetic opioid products while ensuring federal policy is grounded in the best available science. Source: HHS
Porch Light Health speaks on the importance of mental health awareness
Chief Clinical Officer at Porch Light Health speaks with Blake Sammann on 11 News at 9 about the importance of mental health awareness.
FDA-approved epilepsy drug may help reverse osteoarthritis damage
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
China biotech RiboX reveals first data of circular RNA therapies in people
RiboX Therapeutics published first circular RNA clinical data in NEJM, showing RXRG001 improved saliva in xerostomia patients, ahead of Orna, Orbital, and Sail Biomedicines.
Florida Department of Health in Clay County expands services for student athletes
The Florida Department of Health in Clay County has expanded its clinical services to include school and sports physicals along with electrocardiogram screenings.
Andor Health Earns 2026 Frost & Sullivan Competitive Strategy Leadership Recognition for Agentic AI-Based Care Orchestration
/PRNewswire/ -- Andor Health, the leading AI-native clinical services company, today announced it has received Frost & Sullivan's 2026 Competitive Strategy...
50 years ago, my colleagues and I pursued basic research science that became revolutionary
“Basic studies led to clinical and translational advances that no one could have predicted,” Robert Gallo writes of his work with interleukin-2.
Rhode Island Life Science Hub and Cognito Therapeutics Launch Brain Health Collaboratory to Advance Innovation in Alzheimer's Disease
The Rhode Island Life Science Hub (RILSH) and Cognito Therapeutics today announced the launch of the Rhode Island Brain Health Collaboratory, the third Collaboratory in Cognito's growing national network, following collaborations with the West Virginia University Rockefeller Neuroscience Institute in 2025 and Ochsner Health in 2026. Together, RILSH and Cognito will partner to establish a first-of-its-kind statewide platform that brings together research, clinical care, industry, and community pa
HCA Healthcare opens clinical training center in Gainesville
New facility will support nursing and physician education at six North Florida hospitals.
HH Health To Host Hiring Event For Clinical, Nonclinical Positions
Huntsville Hospital Health System will host a community hiring event Wednesday, Oct. 21, from 4 to 7 p.m. at Campus 805’s Stone Event Center, offering job
Istios Health Expands Clinical Research Network into Texas Through Kidney Care Associates Partnership
Partnership strengthens Istios’s growing nephrology research network and expands community-based research capabilities across cardiovascular, kidney, and metabolic diseasesPHOENIX, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Istios Health, a healthcare technology and clinical research company, today announced a partnership with Kidney Care Associates, marking its expansion into Texas and strengthening its national network for cardiovascular-kidney-metabolic (CKM) disease research. The partnership builds o
How Investors May Respond To Encompass Health (EHC) First Maine Hospital Opening
Encompass Health has opened Encompass Health Rehabilitation Hospital of Bangor, a 50 bed inpatient facility in Maine that delivers intensive therapy, frequent physician oversight and 24 hour nursing for patients recovering from complex conditions across a 54,000 square foot site with a wide range of on campus clinical amenities. This Bangor facility is Encompass Health's first wholly owned hospital in Maine. It adds owned capacity in a new state alongside its existing joint venture presence...
Making pediatric cancer more ‘visible’ boosts immunotherapy response
A new preclinical study reveals that blocking a protein makes neuroblastoma cells easier to detect and more vulnerable to treatment.
Why medical group leaders are seeing big leaps in pay
Consultants say compensation is increasing quickly for roles tied to clinical integration, physician alignment and growth.
The Math Singularity Is Here, and Science May Be Next
OpenAI has released an extraordinary body of mathematical work produced by an unreleased frontier model: 722 manuscripts spanning 372 research families across fields including number theory, complexity theory, and mathematical physics. Each result required, on average, the equivalent of roughly three hours of ChatGPT Pro reasoning. A New Era of Discovery We may be witnessing the beginnings of a “math singularity”: a point at which machine-generated discovery accelerates beyond humanity’s ability to independently reproduce, verify, or fully absorb it. If frontier models can generate hundreds of meaningful results in the time it takes a human researcher to investigate one, the constraint will no longer be producing new mathematics. It will be our capacity to validate, interpret, and integrate it. This does not make mathematicians obsolete. It changes their role. They may increasingly serve as guides, critics, and meaning-makers. Increasingly, they will decide which questions matter, determining which results can be trusted, and explaining why they are important. Mathematical insight may become abundant, while human judgment becomes more valuable than ever. Mathematics May Be Only the Beginning Every scientific discipline could eventually experience a similar acceleration. AI systems could generate and test hypotheses, connect findings across specialized fields, and explore possibilities at a scale no human research community could match. In medicine, imagine models identifying overlooked disease mechanisms, designing drugs and clinical trials, personalizing treatments, or discovering cures in months rather than decades. In materials science, AI could help create better batteries and cleaner industrial processes. In climate science, it could accelerate advances in energy, forecasting, and carbon removal. In biology, it could uncover relationships hidden across enormous genomic and molecular datasets. The result would not simply be faster research. It could expand the frontier of what is scientifically possible. The New Bottleneck Scientific discovery, however, is not the same as scientific progress. A medical breakthrough must still survive laboratory testing, clinical trials, regulatory scrutiny, manufacturing constraints, and real-world deployment. As machine-generated ideas multiply, the bottleneck may shift from producing breakthroughs to validating them safely and translating them into practice. We may soon have more hypotheses than laboratories can test, more drugs than clinical trials can evaluate, and more mathematical results than experts can review. That imbalance will require better systems for automated verification, reproducible research, prioritization, peer review, and collaboration between AI and domain experts. The importance of OpenAI’s work is not merely the number of manuscripts produced. It offers a glimpse of a world in which intelligence can explore thousands of intellectual paths in parallel. If ideas cease to be scarce, humanity’s defining challenge will be deciding which are true, which matter, and how to turn them into progress. The math singularity is not the end of human inquiry. It is the beginning of a new kind—one in which machines expand the frontier of knowledge and humans decide where it should lead. Subscribe Share Leave a comment
Committed customer orders at Scinai reach about $7.6 million, up about 300%.
Potential added fees of $5.85 million are indicative and uncommitted; clinical manufacturing under the agreement is planned to start in January 2027.
Atossa Therapeutics Common Stock to Begin Trading with Stapled Contingent Value Rights After Close of Business Today
/PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative...
What Is Culinary Medicine? Bridging Nutrition, Cooking, and Health
Culinary medicine combines nutrition science with practical cooking education to help patients apply dietary advice and train healthcare professionals in nutrition counseling. Studies report improvements in cooking confidence and dietary behaviors, but evidence for sustained clinical benefits remains limited.
Dr. Jeff Bird: Indiana University Health Strives to Provide Excellence in Healthcare
By Dr. Jeff Bird— MUNCIE, IN—IU Health Ball Memorial Hospital provides the primary healthcare service for most of the residents of Delaware County and acts as the tertiary care referral center for East Central Indiana. The clinical care is led by two dedicated clinical leaders: Dr. Ryan Johnston MD, the Chief Medical Officer, and Melissa Hicks, DNP, RN, the Chief Nursing Officer. Under their leadership, the quality and safety of patients hospitalized at IU Health Ball Memorial is vigorously monitored, and processes are in place to continually improve. IU Health Ball was founded in 1929 by funds primarily given by...
Scientists discover a surprising link between vitamin C and cancer survival
A surprising clinical trial suggests that taking vitamin C daily could improve survival in people with precancerous blood disorders and early-stage blood cancers. Patients receiving the supplement had fewer adverse events and showed a promising survival advantage, raising hopes that a common vitamin could help protect against leukemia-related complications.
eClinical Solutions hosts ENGAGE 2026 with 250+ attendees from 75+ life science firms
eClinical Solutions hosts ENGAGE 2026 with 250+ attendees exploring clinical data management solutions for FDA compliance and trial operations.
Balancing Innovation, Access and Operational Excellence
Learn what health plans should consider when evaluating clinical programs, from operational readiness and reporting to flexible care and digital tools.
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
RESEARCH TRIANGLE PARK, N.C., October 07, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today at TechIQ 2026 introduced IQVIA Life Science ModelsTM to help predict clinical trial outcomes.
Integrative Health Meets Clinical Science: OmniActive Launches Fenavari; Names Dr. Taz Bhatia, MD, As Women's Health Partner
/PRNewswire/ -- OmniActive Health Technologies (OmniActive), a global leader in the consumer wellness industry through innovative science and natural...
Proposed AI Governance Framework: Risk-Mitigation Recommendations for Health Plans
Senator Maria Cantwell has outlined a comprehensive AI governance framework intended to drive legislative and executive actions addressing potential AI risks — and for health plans, this framework could determine how AI can be used in prior authorization and other consequential clinical and administrative decisions. The framework explicitly calls out AI-assisted prior authorization — including CMS's WISeR model — as an area where meaningful human oversight is required. Read our alert for six risk-mitigation recommendations health plans should take now.
Characterizing the patient experience: The role of patient‑reported outcomes
Biological endpoints are essential, but on their own, they cannot tell the full story. To truly understand the value of a treatment and care surrounding it, we must also seek to understand how patients and carers experience it. This is where patient-reported outcomes (PROs) and observer‑reported outcomes (reflecting the perspectives of non-clinical caregivers) are becoming more prominent in clinical research.
As prior auth becomes an AI ‘arms race,’ Otter Health raises $8M for a different approach
Prior authorization has long been a source of friction between payers and providers, and now, with algorithmic tools for claims reviews and LLMs for appeals, it's evolved into an AI "arms race" as | The company built an AI-powered real-time clinical quality platform to better manage healthcare utilization by influencing care decisions rather than requiring clinicians to get permission for them.
Michigan State Dominates Northern Michigan in 5-1 Win
First-round picks and veteran transfers powered the Spartans to a season-opening sweep, overcoming a second-period scare to dismantle the Wildcats with a clinical offensive and special teams display.
M42 CEO on AI, genomics and the future of healthcare
M42 Group CEO Dimitris Moulavasilis discusses how the Abu Dhabi-based healthcare company is combining artificial intelligence, genomics and clinical services to reshape healthcare. He explores the group’s international expansion, the Emirati Genome Programme and the potential for technology to help doctors identify health risks earlier and move healthcare towards prevention rather than treatment.
Calcium-rich whey permeate improves bone health in postmenopausal women, study finds
AFI AFI COPENHAGEN, Denmark, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Twice-daily supplementation with calcium-rich whey permeate supports the maintenance of bone mineral density in postmenopausal women, according to a 12-month clinical study.[1] Declining oestrogen levels during menopause can accelerate bone loss and reduce bone mineral density, increasing osteoporosis risk. The findings come from the RENEW project, a research collaboration investigating how calcium-rich permeate from whey production
Health Data Utilities as Essential Public Infrastructure: A Cooperative Federalism Architecture
Federal interoperability initiatives like Trusted Exchange Framework and Common Agreement transport clinical records across boundaries but fail to aggregate and enrich state-governed datasets, including Medicaid claims, prescription monitoring records, and social service registries.
Prostate health: Discover fucoidan at SupplySide Global
Fucoidans are innovative marine ingredients sought after by trusted nutraceutical brands. Ahead of SupplySide Global, Marinova – the global leader in fucoidan science – highlights new clinical findings paving the way for fucoidan to enter the growing men’s health category
Celebrating Excellence in Student Health: District Nurses Earn National Certification - Pine Bush Central School District
We are proud to celebrate two of our very own school nurses, Kathleen Chamberlain and Linda Loennecker, our nursing department chair, for achieving national certification through the National Board for Certification of School Nurses (NBCSN)! Achieving NBCSN certification is a major milestone in school nursing. The rigorous examination tests advanced clinical expertise, specialized knowledge, and … Continue reading "Celebrating Excellence in Student Health: District Nurses Earn National Certification"
Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement
Committed Customer Orders¹ reach approximately $7.6 million, up approximately 300% from $1.9 million at year-end 2025 Agreement with a U.S. based,...
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today at TechIQ 2026 introduced IQVIA Life Science ModelsTM to help predict clinica
UAB Medicine partners with Lawson State Community College to create radiologic technologist pipeline
UAB Medicine and Lawson State Community College have launched a medical radiologic technology training program that creates a direct pathway for UAB Medicine employees to earn a degree, gain hands-on clinical experience, and pursue careers in medical imaging.
Plague is stoppable. The next health threat may not be.
The word plague is scary. Centuries ago, the Black Death killed tens of millions of people and changed the course of history. Plague still kills people around the world, and the word still evokes catastrophe. New fears of plague surfaced on October 2, when a lab worker in Irkutsk, Russia, died of pneumonia. Reports suggested that she may have contracted plague through a laboratory exposure. Understandably, people were alarmed. On October 7, the World Health Organization called for the Russian Federation to be transparent about what it knew. WHO issued an update on October 10. Russian authorities told WHO that testing did not identify plague and that investigations found no laboratory release. WHO said confidence in its risk assessment remained limited and that further clinical, epidemiological, and laboratory information was needed. The cause of the woman’s illness remains unknown, and WHO says a laboratory-associated exposure cannot be excluded. As I explained in a recent interview, this incident is very unlikely to lead to a pandemic. Plague is still active, including in the U.S., which sees a handful of cases each year. But it is a disease we can prevent and treat. Plague doesn’t spread readily, and it responds to antibiotics. The standard response—isolate the patient, trace contacts, and administer antibiotics and monitor for symptoms among contacts for seven days—works. We have even planned for antibiotic-resistant plague. At CDC, we developed a playbook for antibiotic-resistant plague and ran exercises on how to find and stop it. CDC guidance anticipates engineered resistance and recommends two different classes of antibiotics if there’s reason to suspect it. There is no evidence that resistance—or even confirmed plague—is involved in this incident. We have thought through how to address plague, but we’re not ready for the next major health threat that emerges from a lab or from animal spillover to humans. What should concern people is how little stands between the world and the next pathogen to get loose. Since peak COVID, epidemic preparedness has fallen off the political agenda, but the risk is greater than ever. More labs handle dangerous pathogens with more ways to make those pathogens deadlier, and more people live and work in close contact with animals. There are actions we can take now: We need better lab safety in every country. The number of labs that work with dangerous pathogens has increased worldwide over two decades, but there’s no enforceable international standard and no inspection regime; the Biological Weapons Convention, fifty years on, still has no verification mechanism. Labs that study dangerous germs need strong safety systems, training, and oversight. We need to reduce spillover events. Three in four emerging human infections start in animals, and there’s a lot we can do to reduce spillover risk, but the world is doing very little of it. Live-animal markets are one place to act. For instance, closing live-bird markets helped control H7N9 influenza in China. Reducing opportunities for people to encounter infected animals can prevent infections before they become outbreaks. In The Formula for Better Health, which is now out in paperback along with the hardcover, Kindle, and audiobook versions, I argue that labs do too many risky experiments with too many dangerous pathogens in too many institutions, and that every experiment should first answer one basic question: Is the likely benefit greater than the risk? Spillover risk can also be reduced: In the book, I discuss how Brazil cut its deforestation rate by 70% from 2004 to 2012 while increasing agricultural production and reducing risky contact between people and forest animals. We need faster detection and response. Delay costs lives. Strong surveillance, good labs, and trained responders can turn a single case into a small cluster of infections instead of an epidemic. Resolve to Save Lives has worked for nearly a decade to help countries find and stop outbreaks faster. The 7-1-7 target, which Resolve to Save Lives developed with partners in Uganda and elsewhere, provides a clear standard: detect within 7 days, notify within 1 day and complete all essential early response actions within 7 days. In Uganda’s Kasese district, for example, a review of a measles outbreak using 7-1-7 identified shortages of accessible funds, fuel, and vehicles that delayed the response. District leaders established funds they could access quickly. When, a few months later, the Crimean-Congo hemorrhagic fever appeared, the district detected it in three days, notified authorities in one, and mounted an effective response in two. Only one case was confirmed, and the patient survived. Because funds were available before the emergency, authorities were prepared and able to act. This kind of preparation can’t wait until the next crisis begins. Plague is an old disease we that know how to stop. The next threat may be harder to recognize, harder to treat, and easier to spread. Safer labs, less risk of spillover, and faster outbreak detection and response need sustained investment now, while we still have time to prevent the next emergency. Share
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct 7, 2026--
Some people really are werewolves—at least, in their minds
People with clinical lycanthropy are trapped in a body-horror nightmare.
HH Health To Host Hiring Event For Clinical, Nonclinical Positions
Huntsville Hospital Health System will host a community hiring event Wednesday, Oct. 21, from 4 to 7 p.m. at Campus 805’s Stone Event Center, offering job
Daniela Lozano, M.D., Joins Baptist Health Kenneth C. Griffin Neuroscience Institute as a Headache Neurologist - Florida Hospital News and Healthcare Report
October 9, 2026 – Board-certified and fellowship-trained neurologist Daniela Lozano, M.D., has joined Baptist Health Kenneth C. Griffin Neuroscience Institute. Her clinical interests include migraine and other headache disorders, women’s […]
Advancing Women's Health to Improve Outcomes in All Phases of Life
The Executive Order (“EO”) makes it federal policy to prioritize turning women’s health research into better clinical care at every life stage, and it directs HHS, through NIH, to set up a new Women’s Health Division within 90 days. In coordination with the NIH Office of Research on Women’s Health, the Division will focus on, among other things, understudied women’s health conditions, greater inclusion of women and girls in clinical trials and grant recipients’ adherence to NIH's policy on sex as a biological variable. The EO also creates a White House Women’s Health Task Force, co-chaired by the Secretary of HHS and the Assistant to the President and Chief of Staff and composed of officials from other departments and agencies.
Axena Health Named Finalist for the Digital Health Hub Foundation - Digital Health & AI Awards 2026 at HLTH
NEWTON, Mass., October 20, 2026--Axena Health, Inc. (Axena Health), a women’s health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced it has been named a finalist for the Digital Health Hub Foundation – Digital Health & AI Awards 2026 at HLTH. Selected from a pool of more than 1,300 participating companies across all tracks and categories, Axena Health is recognized in the Best in Class Track for Women’s and
South Texas Health System (@stxhealthsystem)
2 likes, 1 comments - stxhealthsystem on October 18, 2026: "Put Your Skills at the Heart of Innovation: South Texas Health System is seeking skilled and dedicated Cardiac Cath Lab Technologists to join the cardiovascular teams at STHS Heart and STHS Edinburg. In this vital role, you’ll support advanced cardiac procedures, help deliver potentially lifesaving care and make a meaningful difference for patients when it matters most. Join a team committed to clinical excellence, innovation and compassionate care. Ready to take your career to the next level? Explore opportunities with the Rio Grande Valley’s largest integrated healthcare network. STHS offers competitive pay, comprehensive benefits and an increased sign-on bonus for qualified applicants. Ready to make your next career move? View current openings and apply at the link in our bio.".
Kettering Health Pharmacist Receives Ohio Resident of the Year Honor
Just months after returning to Kettering Health as a clinical oncology pharmacist, Annie Weckesser has received one of Ohio's top honors for pharmacy residents.
Bellevue Counseling Program Ranked #1 in Nebraska
Bellevue University's Master of Science in Clinical Mental Health Counseling program earned the No. 1 ranking among Clinical Mental Health Counseling master's programs in Nebraska in the 2027 rankings published by MastersinCounseling.org. The ranking recognizes Bellevue University's online, CACREP-accredited graduate program for preparing studen...
Is Teladoc Health (TDOC) Cheap Following Its New AI Tools?
Teladoc Health (TDOC) just rolled out two AI tools inside its Solo platform, SoloVitals and SoloScribe, aimed at contactless vital sign tracking and streamlined clinical note taking for hospital and health system clients. Despite Teladoc Health unveiling AI tools aimed at making virtual visits smoother for hospitals, the 30-day share price return is down 10% and the 90-day move has fallen 41.24%. The 5-year total shareholder return has declined 95.88%, pointing to longer term momentum that...
Three Things We Learned From PSV 2-0 SC Heerenveen
Guus Til’s clinical form rescued a vulnerable defence as Peter Bosz’s side overcame narrow escapes to secure three points ahead of their Champions League trip to Leipzig.
Is Armando 'Hormiga' Gonzalez Playing Today for Olympiacos vs. Panathinaikos?
With Ayoub El Kaabi sidelined, Armando 'La Hormiga' Gonzalez looks to seize his moment as the clinical spearhead in Olympiacos' high-stakes Eternal Enemies showdown against Panathinaikos.
Mental Health Awareness Week
Steve Carleton, Chief Clinical Officer with Porch Light Health joins us in studio to talk about Mental Health Awareness Week.
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct 7, 2026--
Rosalind Franklin University makes leader in simulated clinical education its permanent provost
Longtime Rosalind Franklin University educator James Carlson has been named the North Chicago institution’s permanent provost after serving in an interim role since July 2025.
TAMIU students offer free health screenings in Laredo
Texas A&M International University students are offering free health screenings to the public for the first time at the university’s Clinical Health Sciences Center.
Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation
Oracle today announced an agreement with AstraZeneca to explore how AI and real-world data can help clinicians identify eligible patients for clinical trials, accelerate evidence generation, and bring relevant research insights into everyday care. The collaboration is expected to combine AstraZeneca's scientific and therapeutic expertise with Oracle's health data, cloud, AI, analytics, and clinical workflow capabilities.
A surprisingly simple way to relieve knee arthritis pain without pills or surgery
A surprisingly simple change in how you walk could help relieve knee arthritis pain and even slow joint damage. In a year-long clinical trial, researchers found that adjusting the angle of a person's foot while walking reduced osteoarthritis pain by an amount comparable to medication, without requiring drugs or surgery. Even more promising, MRI scans revealed that participants who adopted the personalized walking technique experienced slower deterioration in a marker of knee cartilage health.
From PMS to Menopause: Two new clinical studies strengthen the science behind one saffron extract
PMS and menopause represent distinct stages of a woman’s life, with different hormonal patterns and symptoms. Yet both are characterised by significant hormonal fluctuations that can influence interconnected biological pathways involved in emotional well-being, sleep, stress response and overall quality of life
Prenosis and Carle Health Mark Sepsis ImmunoScore® Clinical Deployment and First Patients Enrolled in OBSERVE-ARDS Clinical Study
/PRNewswire/ -- Prenosis®, a biology-based technology company delivering precision therapeutics, today announced three milestones in its ongoing relationship...
Michael Lemma: The Science Behind Fenbendazole and Ivermectin Cancer Claims
Michael Lemma: The Science Behind Fenbendazole and Ivermectin Cancer Claims / cancer, cancer treatment, Celebrity Testimonials, clinical evidence, Drug
New £24m children's healthcare facility opens
It brings clinical care and child health technology development under one roof, say hospital bosses.
New ceratiq® Science Expands Skin Health Benefits to Include Sensitive Skin and Dermal Density
/PRNewswire/ -- PLT Health Solutions, Inc. today announced new clinical research on ceratiq® Phytoceramides that expand the ingredient's benefits beyond...
How Hürzeler’s Tactics Have Changed Brighton in 2026/27
The German tactical mastermind has weaponized relentless high-pressing and clinical efficiency, transforming the Seagulls into a fearless scoring machine that currently rivals Europe’s most elite heavyweights.
Rosalind Franklin University makes leader in simulated clinical education its permanent provost
Longtime Rosalind Franklin University educator James Carlson has been named the North Chicago institution’s permanent provost after serving in an interim role since July 2025.
Health expert shares simple ways to help lower inflammation throughout the body
Clinical pharmacist Jim LaValle breaks down how diet, stress, medications, blood sugar, environmental exposures and even overtraining may contribute to inflammation — and why the gut-brain connection matters.
Rush, Endeavor to merge, creating the largest health system in Chicago
As part of the merger, Endeavor will establish $1 billion fund for community health, clinical advances and academic medicine and research.
Medicaid changes discussed by health experts on Staten Island at NAACP town hall event
“My nurses now have to call patients who are going to the emergency department because they’re no longer being seen by their PCP...” said Zakiyah Allen, a registered nurse and clinical manager.
How Team Science at Sylvester is Changing Brain Cancer Care
Sylvester specialists integrate surgery, precision medicine, radiation and clinical trials to advance personalized brain cancer care.
Labcorp to Acquire Select Assets of BioReference Health for $722M
Labcorp will acquire BioReference's lab businesses focused on clinical and women's health testing, urology, and corrections as well as its 4Kscore prostate cancer blood test.
Guardant Health (GH) Stock Looks Below Fair Value On A Huge Run
Guardant Health has turned into a dramatic long term story for shareholders, yet the real question now is whether the current US$158.60 price can be supported by the cash flows its business is expected to produce. With the stock sharply higher over several years and new clinical and regulatory developments landing, the focus has shifted to what the Discounted Cash Flow (DCF) view of its intrinsic value suggests about that price. Over the past 3 years the share price has risen by very large...
Eye Microbiome: How Bacteria May Influence Eye Health and Disease
The ocular surface hosts a low-abundance microbial community that may help regulate immune defenses, while changes in its composition have been associated with inflammatory and infectious eye diseases. Research into the gut-eye axis and microbiome-targeted therapies suggests possible diagnostic and treatment applications, but the underlying mechanisms, causal relationships, and clinical effectiveness remain uncertain.
Verana Health and Bitfount Collaborate to Simplify Prescreening for Ophthalmic Clinical Trials
/PRNewswire/ -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has...
Popular supplement combinations may carry unexpected risks, health expert warns
Clinical pharmacist Jim LaValle discusses why taking excessive amounts of vitamins and minerals can pose health risks, and how identifying nutritional deficiencies can help guide safer supplementation.
Essex mental health patients needed approval to turn off cameras
A clinical team had to assess the requests from mental health patients in Essex, an inquiry hears.
Researchers Discover a Blood-Pressure Drug May Stimulate “Healthy” Brown Fat
Losartan, a drug commonly prescribed for high blood pressure, boosts brown adipose tissue or “brown fat” activity and enhances its metabolism, according to a preclinical study by Weill Cornell Medicine, Rockefeller University and Memorial Sloan Kettering Cancer Center researchers.
NIH Awards Boston University Clinical And Translational Science Institute $41 Million
The National Institutes of Health awarded $41 million to the Boston University Clinical & Translational Science Institute to support its work translating scientific research into new treatments and healthcare technologies.
Women’s health landscape shifting, but systemic hurdles remain
Closing the data gap with inclusionary research and educating investors on the promise of women’s health innovations remain key steps to health equity.
Why child sexual abuse is our biggest public health crisis
An estimated one in five children will experience some form of sexual abuse before the age of 18. In this episode of Settle In, Amna Nawaz speaks with clinical psychologist Elizabeth Letourneau and journalist Luke Malone, authors of “One in Five,” a book that explores child sexual abuse as a public health crisis, about how education and early prevention can help protect children before harm occurs.
MCG and Itiliti Health Form Partnership to Support Health Plans with CMS-0057-F Compliance
/PRNewswire/ -- MCG Health, part of the Hearst Health network and the industry's source of truth for trusted clinical guidance, today announced a strategic...
RWJBARNABAS HEALTH NAMES DR. ERWIN WANG, MD, MHA, SFHM, SENIOR VICE PRESIDENT OF PHYSICIAN PERFORMANCE IMPROVEMENT
RWJBarnabas Health has appointed Erwin Wang, MD, MHA, SFHM, as Senior Vice President of Physician Performance Improvement. In this newly created role, Dr. Wang will lead physician-driven initiatives to enhance clinical quality, patient safety, and value-based care across the health system.
Bridging medicine and care: How China is strengthening international health partnerships
From high-risk surgical care in Benin to stroke interventions in Seychelles, Chinese medical teams abroad are increasingly moving from emergency clinical aid to long-term capacity building. Combining frontline care with specialized malaria control and cataract programs, these health partnerships focus on practical knowledge transfer and serving local populations.
Patient-Owned Health Data Model Reduces Clinical Trial Recruitment Redundancy
Patient-owned health data model reduces clinical trial recruitment redundancy by enabling persistent consent and longitudinal data sharing across studies.
Pfizer makes ‘business decision’ to end phase 2 trial of autoimmune drug as program’s future uncertain
Pfizer has called time on a phase 2 trial of its CXCR5 antibody in an autoimmune blood disorder, with the company tight-lipped on whether this marks the end of the road for the asset. The Big Pharma had been evaluating the therapy, dubbed PF-06835375, in a phase 2 study of 61 patients with primary immune thrombocytopenia (ITP) that kicked off in 2022, according to the federal trials register. However, Pfizer confirmed to Fierce on Monday that this study had been terminated “due to a business decision.” “The decision to terminate the trial was not based on any safety concerns,” a spokesperson pointed out. At time of publication, PF-06835375 remained listed on Pfizer’s website for both ITP and lupus. A phase 1 study in lupus wrapped up in 2022, according to the trials database. ITP is an autoimmune disorder characterized by a low platelet count. Novartis was at one point evaluating its B-cell-depleting antibody ianalumab—recently approved as Fabhalta to treat immunoglobulin A nephropathy—as a potential treatment ITP. But the therapy struggled to demonstrate a benefit in the clinic for this indication. When contacted by Fierce, Pfizer wouldn’t confirm whether all work on PF-06835375 has been halted, and whether the company has any other plans to explore C-X-C chemokine receptor type 5 (CXCR5) as a mechanism. CXCR5 is found in blood cancers such as diffuse large B-cell lymphoma and mantle cell lymphoma chemokine receptor. However, there is little expression in normal tissue, which has led some drug developers to explore its potential. Vincerx Pharma had at one point been planning to take an anti-CXCR5 ADC into the clinic to treat B-cell malignancies, but that ambition was scrapped due to cash constraints. Where Big Pharma is placing its bets is one of the hot topics being discussed at Fierce Biotech's high-impact event in London next month. Find out more information and register by clicking on the banner below: [ ](https://qtxasset.com/quartz/qcloud5/media/image/where_big_pharma_is_placing_its_bets.png?VersionId=B8JrRbJ.pFUSK1pJgjeWHLGm_18RdLAy)
Doctors may be getting childhood obesity wrong, new research suggests
A Lancet Commission definition of clinical obesity cuts pediatric rates sharply by requiring evidence of health complications beyond body mass index.
UVA Health physician dispels common misconceptions about antibiotics
Studies suggest that the old clinical axiom that patients must finish the entire course of antibiotics when treating infections may call for more nuance.
Philips Oral Healthcare establishes Global Clinical Advisory Board to help shape the future of oral care through scientific and clinical insight
Philips Sonicare establishes a Global Clinical Advisory Board of dental experts to provide scientific, clinical and strategic guidance.
Ruiling Yuan: Building Trust and Health Literacy to Expand Clinical Trial Participation
Ruiling Yuan: Building Trust and Health Literacy to Expand Clinical Trial Participation / cancer, clinical trial, clinical trials, Jennifer Clary, Joanna K.
Weekly Rundown: Nextech taps Assort Health, EliseAI for agentic AI; Elsevier rolls out clinical AI tool for nurses
Stay up to date on the latest in health tech, digital health and health AI news with this weekly brief. Read below for news from the week of Oct. 5 to 9. | The latest news from Nextech, Assort Health, EliseAI, Elsevier, Arcadia, Solera Health and more.
Cigna Group (CI) Could Be 56% Undervalued Following Its Health Sense Rollout
Health Sense rollout and what it could mean for Cigna Group stock Cigna Group (CI) has put its Health Sense platform at the center of a push to link health data, benefits and clinical support into a single experience for oncology and cardiometabolic patients. The model ties together information on medical history, behavioral health, pharmacy coverage, prior interactions and expected costs, then uses that context to tailor outreach and care coordination through existing Cigna Healthcare...
Rush, Endeavor to merge, creating the largest health system in Chicago
As part of the merger, Endeavor will establish $1 billion fund for community health, clinical advances and academic medicine and research.
Dartmouth Health Addresses Rural Hospice, Palliative Care Disparities
End-of-life care disparities proliferate across rural and remote regions, often due to insufficient clinical home-based resources. Dartmouth Health
egnite's Call for Science Study on M-TEER Device Durability and Long-Term Patient Outcomes to be Featured at TCT 2026
egnite, Inc., a cardiovascular intelligence company that helps clinicians identify and manage patients with untreated heart disease, today announced that Dr. John T. Saxon, Director of the Advanced Cardiac Valve Center at University of Virginia (UVA) Health, has been selected as the winner of its inaugural Call for Science grant program. His study, Long-Term Durability After Successful M-TEER: Insights from a Large, Real-World Imaging Database, will be presented as Featured Clinical Research at
South Texas Health System (@stxhealthsystem)
0 likes, 1 comments - stxhealthsystem on October 11, 2026: "Lead the Future of Healthcare with STHS: South Texas Health System, the Rio Grande Valley’s largest integrated healthcare network, is seeking experienced, driven healthcare professionals who are passionate about delivering quality, compassionate care to join our leadership team. Current leadership opportunities include: • Assistant Chief Nursing Officer (STHS Edinburg/Cornerstone) • System Market Director – Freestanding Emergency Department (STHS) • Director of Nursing, ICU (STHS Heart) • Director of Nursing, ER (STHS McAllen) At STHS, our leaders help shape the future of healthcare by advancing clinical excellence, enhancing operational effectiveness and empowering care teams to achieve their fullest potential. Through their commitment to safety, quality and patient-centered care, they make a lasting impact on the health and well-being of the communities we serve. If you're ready to lead with purpose, inspire excellence and make a meaningful difference, explore these opportunities and take the next step in your career with an organization that values leadership, service and innovation. For details and to apply, visit the link in our bio.".
Flahy uses knowledge graphs to support AI-powered healthcare
Flahy uses knowledge graphs to connect biological and clinical data, supporting personalized decisions in AI-powered healthcare.
St Vincent's Australia convenes first national AI Clinical Council
The council will guide the evaluation and adoption of AI technologies across its hospitals, aged care facilities and home-based services.
How Behavioral Science Can Get Shoppers To Buy (and Eat) More Fresh Produce
Industry leaders at IFPA’s Global Produce and Floral Show revealed that overcoming flat fruit and vegetable consumption requires shifting away from clinical health messaging toward flavor-forward marketing, cultural rituals and frictionless convenience.